Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

C4 Therapeutics (United States) | Researchclopedia

Back to institutions

C4 Therapeutics (United States)

Watertown, Massachusettscompany

204

Works

10,903

Citations

42

h-index

Top Research Topics

Protein Degradation and Inhibitors Ubiquitin and proteasome pathways CAR-T cell therapy research

Top Researchers

Patrick A. Baeuerle C4 Therapeutics (United States)

450 works64,335 citationsh-index: 122

Recent Research

The post-pandemic pivot: mRNA therapeutics enter the chronic rare disease arena

Paloma H. Giangrande

20260 citations

Cancer Immunotherapy and Biomarkers

Immunotherapy and Immune Responses

Multiple Myeloma Research and Treatments

RNA modifications and cancer

RNA and protein synthesis mechanisms

Monoclonal and Polyclonal Antibodies Research

Protein Structure and Dynamics

RNA Research and Splicing

Peptidase Inhibition and Analysis

Wendy S. Garrett Broad Institute

267 works63,300 citationsh-index: 78

Daniel J. Hicklin C4 Therapeutics (United States)

349 works52,898 citationsh-index: 103

Francesco M. Marincola Center for Translational Molecular Medicine

882 works51,409 citationsh-index: 109

Stephen L. Archer Queen's University

496 works46,364 citationsh-index: 104

Andrew E. Jaffe Johns Hopkins University

318 works39,011 citationsh-index: 70

Development of Reaction-Centered Encoders and Benchmarking of Enzyme-Reaction Pair Models

Stefan C. Pate,Eric H. Wang,et al.

20260 citations

An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice

Sima Qutaina,Haitian ZHAO,et al.

20260 citations

Integration of multiomic and multi-phenotypic data identifies biological pathways associated with physical fitness

Azar Alizadeh,John Graf,et al.

20260 citations

WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike “Non-Alpha” Muteins

Christopher J. Nirschl,Kulandayan K. Subramanian,et al.

20260 citations

Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics

Thomas M Schmitt,Kelsey Furiya,et al.

20260 citations